Cas:340318-80-1 1-[2-(2-Chlorophenoxy)ethyl]-1H-indole-3-carbaldehyde manufacturer & supplier

We serve Chemical Name:1-[2-(2-Chlorophenoxy)ethyl]-1H-indole-3-carbaldehyde CAS:340318-80-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-[2-(2-Chlorophenoxy)ethyl]-1H-indole-3-carbaldehyde

Chemical Name:1-[2-(2-Chlorophenoxy)ethyl]-1H-indole-3-carbaldehyde
CAS.NO:340318-80-1
Synonyms:1-[2-(2-chlorophenoxy)ethyl]indole-3-carbaldehyde
Molecular Formula:C17H14ClNO2
Molecular Weight:299.75200
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:491ºC at 760 mmHg
Density:1.22g/cm3
Index of Refraction:1.603
PSA:31.23000
Exact Mass:299.07100
LogP:4.18620

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-[2-(2-chlorophenoxy)ethyl]indole-3-carbaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-[2-(2-chlorophenoxy)ethyl]indole-3-carbaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-[2-(2-chlorophenoxy)ethyl]indole-3-carbaldehyde Use and application,1-[2-(2-chlorophenoxy)ethyl]indole-3-carbaldehyde technical grade,usp/ep/jp grade.


Related News: That’s four days earlier than it had initially planned. Delta’s last China-bound flight left on Saturday, February 1, and its final returning flight from China to the United States leaves on Sunday. 1-[2-(2-Chlorophenoxy)ethyl]-1H-indole-3-carbaldehyde manufacturer ��CAR T-cell therapy continues to deliver remarkable outcomes for patients with hematologic malignancies, and next-generation approaches are needed to enable broad and timely patient access and reduce the cost and complexity of therapy,�� said Scott Wolchko, President and Chief Executive Officer of Fate Therapeutics. 1-[2-(2-Chlorophenoxy)ethyl]-1H-indole-3-carbaldehyde supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 1-[2-(2-Chlorophenoxy)ethyl]-1H-indole-3-carbaldehyde vendor The Biogen Inc (BIIB.O) drug, Aduhelm, was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer’s, rather than proof that it slows progression of the lethal mind-wasting disease. 1-[2-(2-Chlorophenoxy)ethyl]-1H-indole-3-carbaldehyde factory Over the years, large international pharmaceutical companies have gradually focused on the research and development and sales of patented drugs, and have gradually outsourced traditional products. Among them, most of the contractors are pharmaceutical companies in emerging countries.